166 related articles for article (PubMed ID: 6974884)
1. Subsensitivity of serotonin receptors after long-term treatment of rats with fluoxetine.
Wong DT; Bymaster FP
Res Commun Chem Pathol Pharmacol; 1981 Apr; 32(1):41-51. PubMed ID: 6974884
[TBL] [Abstract][Full Text] [Related]
2. The pharmacologic profile of fluoxetine.
Stark P; Fuller RW; Wong DT
J Clin Psychiatry; 1985 Mar; 46(3 Pt 2):7-13. PubMed ID: 3871767
[TBL] [Abstract][Full Text] [Related]
3. [3H]8-OH-DPAT binding and serotonin content in rat cerebral cortex after acute fluoxetine, desipramine, or pargyline.
Carli M; Afkhami-Dastjerdian S; Reader TA
J Psychiatry Neurosci; 1996 Mar; 21(2):114-22. PubMed ID: 8820177
[TBL] [Abstract][Full Text] [Related]
4. Effects of repeated treatment with fluoxetine and citalopram, 5-HT uptake inhibitors, on 5-HT1A and 5-HT2 receptors in the rat brain.
Klimek V; Zak-Knapik J; Mackowiak M
J Psychiatry Neurosci; 1994 Jan; 19(1):63-7. PubMed ID: 8148368
[TBL] [Abstract][Full Text] [Related]
5. [Central serotonin receptors and chronic treatment with selective serotonin reuptake inhibitors in the rat: comparative effects of fluoxetine and paroxetine].
Le Poul E; Lima L; Laporte AM; Even C; Doucet E; Fattaccini CM; Laaris N; Hamon M; Lanfumey L
Encephale; 1995; 21(2):123-32. PubMed ID: 7781583
[TBL] [Abstract][Full Text] [Related]
6. Antidepressant-induced increase in high-affinity rolipram binding sites in rat brain: dependence on noradrenergic and serotonergic function.
Zhao Y; Zhang HT; O'Donnell JM
J Pharmacol Exp Ther; 2003 Oct; 307(1):246-53. PubMed ID: 12954819
[TBL] [Abstract][Full Text] [Related]
7. Chronic fluoxetine treatment upregulates 5-HT uptake sites and 5-HT2 receptors in rat brain: an autoradiographic study.
Hrdina PD; Vu TB
Synapse; 1993 Aug; 14(4):324-31. PubMed ID: 8248854
[TBL] [Abstract][Full Text] [Related]
8. The comparison of fluoxetine and nisoxetine with tricyclic antidepressants in blocking the neurotoxicity of p-chloroamphetamine and 6-hydroxydopamine in the rat brain.
Wong DT; Bymaster FP
Res Commun Chem Pathol Pharmacol; 1976 Oct; 15(2):221-31. PubMed ID: 981783
[TBL] [Abstract][Full Text] [Related]
9. Monoamine oxidase inhibitors and serotonin uptake inhibitors: differential effects on [3H]serotonin binding sites in rat brain.
Savage DD; Mendels J; Frazer A
J Pharmacol Exp Ther; 1980 Feb; 212(2):259-63. PubMed ID: 7351637
[TBL] [Abstract][Full Text] [Related]
10. Identification of 5-hydroxytryptamine7 receptor binding sites in rat hypothalamus: sensitivity to chronic antidepressant treatment.
Sleight AJ; Carolo C; Petit N; Zwingelstein C; Bourson A
Mol Pharmacol; 1995 Jan; 47(1):99-103. PubMed ID: 7838138
[TBL] [Abstract][Full Text] [Related]
11. Tianeptine, a specific serotonin uptake enhancer, decreases ethanol intake in rats.
Daoust M; Compagnon P; Legrand E; Mocaër E
Alcohol Alcohol; 1992 Jan; 27(1):15-7. PubMed ID: 1580922
[TBL] [Abstract][Full Text] [Related]
12. Effects of subchronic antidepressant drug treatment on central serotonergic mechanisms in the male rat.
Fuxe K; Ogren SO; Agnati LF; Andersson K; Eneroth P
Adv Biochem Psychopharmacol; 1982; 31():91-107. PubMed ID: 7080902
[TBL] [Abstract][Full Text] [Related]
13. [3H]tetrahydrotrazodone binding. Association with serotonin binding sites.
Kendall DA; Taylor DP; Enna SJ
Mol Pharmacol; 1983 May; 23(3):594-9. PubMed ID: 6865906
[TBL] [Abstract][Full Text] [Related]
14. Multiple 3H-5-hydroxytryptamine binding sites in rat brain.
Nelson DL; Pedigo NW; Yamamura HI
J Physiol (Paris); 1981; 77(2-3):369-72. PubMed ID: 7288652
[TBL] [Abstract][Full Text] [Related]
15. [Characteristics of 3H-paroxetine-labeled serotonin uptake sites in rat brain].
Yoshida Y
Yakubutsu Seishin Kodo; 1988 Jun; 8(2):345-57. PubMed ID: 2975437
[TBL] [Abstract][Full Text] [Related]
16. Manipulations of synaptic serotonin: discrepancy of effects on serotonin S1 and S2 sites.
Dumbrille-Ross A; Tang SW
Life Sci; 1983 Jun; 32(23):2677-84. PubMed ID: 6602261
[TBL] [Abstract][Full Text] [Related]
17. S 15535, a novel benzodioxopiperazine ligand of serotonin (5-HT)1A receptors: I. Interaction with cloned human (h)5-HT1A, dopamine hD2/hD3 and h alpha2A-adrenergic receptors in relation to modulation of cortical monoamine release and activity in models of potential antidepressant activity.
Millan MJ; Newman-Tancredi A; Rivet JM; Brocco M; Lacroix P; Audinot V; Cistarelli L; Gobert A
J Pharmacol Exp Ther; 1997 Jul; 282(1):132-47. PubMed ID: 9223549
[TBL] [Abstract][Full Text] [Related]
18. [Mechanism of action of various psychotropic agents on serotonin receptors and the transmembrane signal control].
Mikuni M
Hokkaido Igaku Zasshi; 1987 May; 62(3):417-29. PubMed ID: 3610034
[TBL] [Abstract][Full Text] [Related]
19. Fluoxetine and two other serotonin uptake inhibitors without affinity for neuronal receptors.
Wong DT; Bymaster FP; Reid LR; Threlkeld PG
Biochem Pharmacol; 1983 Apr; 32(7):1287-93. PubMed ID: 6303355
[TBL] [Abstract][Full Text] [Related]
20. Central pre- and postsynaptic 5-HT1A receptors in rats treated chronically with a novel antidepressant, cericlamine.
Jolas T; Haj-Dahmane S; Kidd EJ; Langlois X; Lanfumey L; Fattaccini CM; Vantalon V; Laporte AM; Adrien J; Gozlan H
J Pharmacol Exp Ther; 1994 Mar; 268(3):1432-43. PubMed ID: 8138956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
